Philadelphia, PA, October 13, 2014 – There has been much interest in the potential for using probiotic bacteria for treating skin diseases and other disorders. Japanese researchers have now found that ...
The Kirin Group Vision 2027 sets out the broad goal of creating value across the world of food & beverages to pharmaceuticals and becoming a global leader in CSV*2. To augment the Group’s existing ...
NEW YORK — Kyowa Hakko Bio Co., Ltd., a subsidiary of Kirin Holdings Co., Ltd., Tokyo, launched Immuse, a novel dietary supplement ingredient, in the United States. Immuse is a patented Lactococcus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results